Annual Operating Profit
-$34.42 M
+$31.60 M+47.86%
31 December 2022
Summary:
Eloxx Pharmaceuticals annual operaing income is currently -$34.42 million, with the most recent change of +$31.60 million (+47.86%) on 31 December 2022. During the last 3 years, it has fallen by -$4.98 million (-16.92%).ELOX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$3.64 M
+$503.00 K+12.15%
30 September 2023
Summary:
Eloxx Pharmaceuticals quarterly operating income is currently -$3.64 million, with the most recent change of +$503.00 thousand (+12.15%) on 30 September 2023. ELOX quarterly operating profit is now -963.76% below its all-time high of -$341.90 thousand, reached on 31 March 2017.ELOX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$19.29 M
+$3.50 M+15.38%
30 September 2023
Summary:
Eloxx Pharmaceuticals TTM operating income is currently -$19.29 million, with the most recent change of +$3.50 million (+15.38%) on 30 September 2023. ELOX TTM operating profit is now -4722.00% below its all-time high of -$400.00 thousand, reached on 31 December 1999.ELOX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELOX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -16.9% | +64.5% | +67.9% |
| 5 y5 years | +26.7% | +71.5% | +63.7% |
ELOX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -16.9% | +47.9% | at high | +68.7% | at high | +71.9% |
| 5 y | 5 years | -16.9% | +47.9% | at high | +89.8% | at high | +71.9% |
| alltime | all time | <-9999.0% | +47.9% | -963.8% | +89.8% | -4722.0% | +71.9% |
Eloxx Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$3.64 M(-12.1%) | -$19.29 M(-15.4%) |
| June 2023 | - | -$4.14 M(-24.5%) | -$22.79 M(-21.3%) |
| Mar 2023 | - | -$5.48 M(-9.0%) | -$28.95 M(-15.9%) |
| Dec 2022 | -$34.42 M(-47.9%) | -$6.03 M(-15.6%) | -$34.42 M(-14.0%) |
| Sept 2022 | - | -$7.14 M(-30.6%) | -$40.02 M(-7.2%) |
| June 2022 | - | -$10.30 M(-6.0%) | -$43.12 M(-37.1%) |
| Mar 2022 | - | -$10.95 M(-5.8%) | -$68.56 M(+3.8%) |
| Dec 2021 | -$66.02 M(+124.3%) | -$11.63 M(+13.5%) | -$66.02 M(+9.7%) |
| Sept 2021 | - | -$10.24 M(-71.3%) | -$60.17 M(+7.0%) |
| June 2021 | - | -$35.73 M(+324.6%) | -$56.22 M(+100.2%) |
| Mar 2021 | - | -$8.41 M(+45.5%) | -$28.08 M(-4.6%) |
| Dec 2020 | -$29.44 M(-41.8%) | -$5.78 M(-8.2%) | -$29.44 M(-16.2%) |
| Sept 2020 | - | -$6.30 M(-17.0%) | -$35.14 M(-15.6%) |
| June 2020 | - | -$7.59 M(-22.4%) | -$41.63 M(-13.9%) |
| Mar 2020 | - | -$9.77 M(-14.9%) | -$48.35 M(-4.4%) |
| Dec 2019 | -$50.55 M(+7.6%) | -$11.49 M(-10.1%) | -$50.55 M(-4.9%) |
| Sept 2019 | - | -$12.78 M(-10.7%) | -$53.18 M(+2.7%) |
| June 2019 | - | -$14.31 M(+19.5%) | -$51.76 M(+1.2%) |
| Mar 2019 | - | -$11.98 M(-15.1%) | -$51.16 M(+12.0%) |
| Dec 2018 | -$46.97 M(+145.9%) | -$14.11 M(+24.2%) | -$45.68 M(+44.7%) |
| Sept 2018 | - | -$11.36 M(-17.1%) | -$31.56 M(+51.5%) |
| June 2018 | - | -$13.71 M(+111.2%) | -$20.83 M(+172.2%) |
| Mar 2018 | - | -$6.49 M(+934.6%) | -$7.65 M(+280.8%) |
| Dec 2017 | -$19.10 M(+791.4%) | - | - |
| Sept 2017 | - | -$627.60 K(+17.7%) | -$2.01 M(-6.2%) |
| June 2017 | - | -$533.00 K(+55.9%) | -$2.14 M(-7.1%) |
| June 2017 | -$2.14 M(-42.3%) | - | - |
| Mar 2017 | - | -$341.90 K(-32.6%) | -$2.31 M(-19.7%) |
| Dec 2016 | - | -$507.50 K(-33.2%) | -$2.87 M(-13.6%) |
| Sept 2016 | - | -$760.20 K(+9.1%) | -$3.32 M(-10.5%) |
| June 2016 | -$3.71 M(-51.5%) | -$696.50 K(-23.3%) | -$3.71 M(-5.7%) |
| Mar 2016 | - | -$908.10 K(-5.2%) | -$3.94 M(-7.5%) |
| Dec 2015 | - | -$958.10 K(-16.8%) | -$4.25 M(-28.2%) |
| Sept 2015 | - | -$1.15 M(+25.3%) | -$5.92 M(-22.7%) |
| June 2015 | -$7.66 M(+10.7%) | -$919.00 K(-25.0%) | -$7.66 M(-8.6%) |
| Mar 2015 | - | -$1.23 M(-53.3%) | -$8.38 M(-9.7%) |
| Dec 2014 | - | -$2.63 M(-9.3%) | -$9.29 M(+12.6%) |
| Sept 2014 | - | -$2.89 M(+76.9%) | -$8.25 M(+19.2%) |
| June 2014 | -$6.92 M(+50.9%) | -$1.64 M(-23.1%) | -$6.92 M(+10.2%) |
| Mar 2014 | - | -$2.13 M(+34.0%) | -$6.28 M(+20.9%) |
| Dec 2013 | - | -$1.59 M(+1.4%) | -$5.20 M(+5.9%) |
| Sept 2013 | - | -$1.57 M(+57.4%) | -$4.91 M(+7.0%) |
| June 2013 | -$4.59 M(-9.9%) | -$995.80 K(-4.6%) | -$4.59 M(-5.2%) |
| Mar 2013 | - | -$1.04 M(-19.7%) | -$4.84 M(-1.3%) |
| Dec 2012 | - | -$1.30 M(+4.3%) | -$4.90 M(-3.1%) |
| Sept 2012 | - | -$1.25 M(+0.1%) | -$5.06 M(-0.7%) |
| June 2012 | -$5.09 M(-16.4%) | -$1.25 M(+12.3%) | -$5.09 M(+4.9%) |
| Mar 2012 | - | -$1.11 M(-23.9%) | -$4.85 M(-5.1%) |
| Dec 2011 | - | -$1.46 M(+13.7%) | -$5.11 M(-0.9%) |
| Sept 2011 | - | -$1.28 M(+27.0%) | -$5.16 M(-15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | -$6.09 M(+25.6%) | -$1.01 M(-26.3%) | -$6.09 M(-10.6%) |
| Mar 2011 | - | -$1.37 M(-9.1%) | -$6.81 M(+3.8%) |
| Dec 2010 | - | -$1.50 M(-31.8%) | -$6.56 M(+8.1%) |
| Sept 2010 | - | -$2.21 M(+27.6%) | -$6.07 M(+25.2%) |
| June 2010 | -$4.85 M(+13.1%) | -$1.73 M(+54.2%) | -$4.85 M(+11.6%) |
| Mar 2010 | - | -$1.12 M(+10.7%) | -$4.34 M(+2.9%) |
| Dec 2009 | - | -$1.01 M(+3.0%) | -$4.22 M(-4.9%) |
| Sept 2009 | - | -$983.70 K(-19.7%) | -$4.43 M(+3.5%) |
| June 2009 | -$4.28 M(+19.1%) | -$1.22 M(+22.7%) | -$4.28 M(+5.9%) |
| Mar 2009 | - | -$997.70 K(-18.8%) | -$4.04 M(-6.4%) |
| Dec 2008 | - | -$1.23 M(+47.2%) | -$4.32 M(+6.3%) |
| Sept 2008 | - | -$834.30 K(-15.3%) | -$4.06 M(+12.9%) |
| June 2008 | -$3.60 M(+8.4%) | -$984.50 K(-22.6%) | -$3.60 M(+7.8%) |
| Mar 2008 | - | -$1.27 M(+30.9%) | -$3.34 M(+15.6%) |
| Dec 2007 | - | -$971.90 K(+162.2%) | -$2.89 M(-6.2%) |
| Sept 2007 | - | -$370.70 K(-48.9%) | -$3.08 M(-7.2%) |
| June 2007 | -$3.32 M(-2.9%) | -$725.60 K(-11.7%) | -$3.32 M(-2.4%) |
| Mar 2007 | - | -$822.20 K(-29.2%) | -$3.40 M(+2.4%) |
| Dec 2006 | - | -$1.16 M(+90.0%) | -$3.32 M(+7.1%) |
| Sept 2006 | - | -$611.40 K(-24.2%) | -$3.10 M(-9.3%) |
| June 2006 | -$3.42 M(+2.9%) | -$806.10 K(+8.6%) | -$3.42 M(-1.6%) |
| Mar 2006 | - | -$742.00 K(-21.2%) | -$3.47 M(-4.9%) |
| Dec 2005 | - | -$941.70 K(+1.3%) | -$3.65 M(+3.8%) |
| Sept 2005 | - | -$929.50 K(+8.1%) | -$3.52 M(+6.0%) |
| June 2005 | -$3.32 M(-17.7%) | -$860.00 K(-6.7%) | -$3.32 M(-14.5%) |
| Mar 2005 | - | -$922.00 K(+14.1%) | -$3.88 M(+8.7%) |
| Dec 2004 | - | -$808.20 K(+10.5%) | -$3.57 M(-2.5%) |
| Sept 2004 | - | -$731.50 K(-48.5%) | -$3.66 M(-15.7%) |
| June 2004 | -$4.04 M(+78.0%) | -$1.42 M(+132.9%) | -$4.34 M(+27.4%) |
| Mar 2004 | - | -$610.50 K(-32.1%) | -$3.41 M(+2.4%) |
| Dec 2003 | - | -$898.70 K(-36.3%) | -$3.33 M(+5.9%) |
| Sept 2003 | - | -$1.41 M(+189.7%) | -$3.14 M(+38.5%) |
| June 2003 | -$2.27 M(+7.3%) | -$487.20 K(-8.4%) | -$2.27 M(+5.5%) |
| Mar 2003 | - | -$532.10 K(-25.3%) | -$2.15 M(+1.7%) |
| Dec 2002 | - | -$712.10 K(+32.6%) | -$2.11 M(-1.8%) |
| Sept 2002 | - | -$537.20 K(+45.3%) | -$2.15 M(+1.9%) |
| June 2002 | -$2.11 M(+7.3%) | -$369.60 K(-25.4%) | -$2.11 M(-2.1%) |
| Mar 2002 | - | -$495.50 K(-34.1%) | -$2.16 M(+2.0%) |
| Dec 2001 | - | -$751.40 K(+51.0%) | -$2.12 M(+8.9%) |
| Sept 2001 | - | -$497.70 K(+19.8%) | -$1.95 M(-1.3%) |
| June 2001 | -$1.97 M(-19.5%) | -$415.60 K(-8.4%) | -$1.97 M(-9.6%) |
| Mar 2001 | - | -$453.90 K(-21.6%) | -$2.18 M(-14.6%) |
| Dec 2000 | - | -$579.00 K(+10.8%) | -$2.55 M(+7.5%) |
| Sept 2000 | - | -$522.60 K(-16.4%) | -$2.38 M(+28.2%) |
| June 2000 | -$2.45 M(+111.7%) | -$625.30 K(-24.4%) | -$1.85 M(+50.9%) |
| Mar 2000 | - | -$827.40 K(+106.8%) | -$1.23 M(+206.8%) |
| Dec 1999 | - | -$400.00 K | -$400.00 K |
| June 1999 | -$1.16 M(<-9900.0%) | - | - |
| June 1998 | $0.00(0.0%) | - | - |
| June 1997 | $0.00 | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Eloxx Pharmaceuticals?
What is Eloxx Pharmaceuticals annual operaing income?
The current annual operating profit of ELOX is -$34.42 M
What is the all time high annual operating profit for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual operaing income is $0.00
What is Eloxx Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ELOX is -$3.64 M
What is the all time high quarterly operating profit for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly operating income is -$341.90 K
What is Eloxx Pharmaceuticals TTM operating income?
The current TTM operating profit of ELOX is -$19.29 M
What is the all time high TTM operating profit for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM operating income is -$400.00 K